English
简体中文
Total: £ 56.28
Published Date: 2026-04-10 | Pages: 137 | Tables: 140 | Pharma & Healthcare
The global Emphysema Treatment Medication market was valued at US$ 4392 million in 2025 and is anticipated to reach US$ 5488 million by 2032, at a CAGR of 3.3% from 2026 to 2032.
Emphysema is a chronic and progressive lung condition characterized by damage to the air sacs in the lungs, known as alveoli. This damage leads to the deterioration of the lung tissue and results in decreased elasticity, making it difficult to breathe. The primary cause of emphysema is long-term exposure to irritants, most commonly cigarette smoke, although other factors such as air pollution and genetic predisposition can also contribute. Symptoms of emphysema include shortness of breath, chronic coughing, wheezing, and tightness in the chest. Treatment for emphysema focuses on managing symptoms and slowing down the progression of the disease. Medication is the therapeutic interventions for emphysema treatment.
Surge in prevalence of emphysema and rise in number of smokers are expected to drive the growth of the emphysema treatment market. For instance, according to 2024 article by American Lung Association, it was estimated that over 3 million people in the U.S. have been diagnosed with emphysema. Furthermore, according to a report by Foundation for a Smoke-Free World, it was reported that prevalence of smoking in India was estimated to be 4.6%.
This report delivers a comprehensive overview of the global Emphysema Treatment Medication market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Emphysema Treatment Medication. The Emphysema Treatment Medication market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Emphysema Treatment Medication market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Emphysema Treatment Medication manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Emphasys Medical
Pfizer
Uptake Medical
Inogen, Inc
Viatris Inc
Boehringer Ingelheim International GmbH
Novartis AG
AstraZeneca
Orion Corporation
Teva Pharmaceutical Industries Ltd
Verona Pharma Plc
GlaxoSmithKline Plc
Pulmonx
Bioxyne
Intrexon
Icure Pharmaceuticals
Kamada
Segment by Type
Bronchodilators
Steroids
Others
Segment by Application
Hospitals
Homecare
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Emphysema Treatment Medication companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Emphysema Treatment Medication Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Bronchodilators
1.2.3 Steroids
1.2.4 Others
1.3 Market by Application
1.3.1 Global Emphysema Treatment Medication Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Emphysema Treatment Medication Market Perspective (2021–2032)
2.2 Global Emphysema Treatment Medication Growth Trends by Region
2.2.1 Global Emphysema Treatment Medication Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Emphysema Treatment Medication Historic Market Size by Region (2021–2026)
2.2.3 Emphysema Treatment Medication Forecasted Market Size by Region (2027–2032)
2.3 Emphysema Treatment Medication Market Dynamics
2.3.1 Emphysema Treatment Medication Industry Trends
2.3.2 Emphysema Treatment Medication Market Drivers
2.3.3 Emphysema Treatment Medication Market Challenges
2.3.4 Emphysema Treatment Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Emphysema Treatment Medication Players by Revenue
3.1.1 Global Top Emphysema Treatment Medication Players by Revenue (2021–2026)
3.1.2 Global Emphysema Treatment Medication Revenue Market Share by Players (2021–2026)
3.2 Global Top Emphysema Treatment Medication Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Emphysema Treatment Medication Revenue
3.4 Global Emphysema Treatment Medication Market Concentration Ratio
3.4.1 Global Emphysema Treatment Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Emphysema Treatment Medication Revenue in 2025
3.5 Global Key Players of Emphysema Treatment Medication Head Offices and Areas Served
3.6 Global Key Players of Emphysema Treatment Medication, Products and Applications
3.7 Global Key Players of Emphysema Treatment Medication, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Emphysema Treatment Medication Breakdown Data by Type
4.1 Global Emphysema Treatment Medication Historic Market Size by Type (2021–2026)
4.2 Global Emphysema Treatment Medication Forecasted Market Size by Type (2027–2032)
5 Emphysema Treatment Medication Breakdown Data by Application
5.1 Global Emphysema Treatment Medication Historic Market Size by Application (2021–2026)
5.2 Global Emphysema Treatment Medication Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Emphysema Treatment Medication Market Size (2021–2032)
6.2 North America Emphysema Treatment Medication Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Emphysema Treatment Medication Market Size by Country (2021–2026)
6.4 North America Emphysema Treatment Medication Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Emphysema Treatment Medication Market Size (2021–2032)
7.2 Europe Emphysema Treatment Medication Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Emphysema Treatment Medication Market Size by Country (2021–2026)
7.4 Europe Emphysema Treatment Medication Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Emphysema Treatment Medication Market Size (2021–2032)
8.2 Asia-Pacific Emphysema Treatment Medication Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Emphysema Treatment Medication Market Size by Region (2021–2026)
8.4 Asia-Pacific Emphysema Treatment Medication Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Emphysema Treatment Medication Market Size (2021–2032)
9.2 Latin America Emphysema Treatment Medication Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Emphysema Treatment Medication Market Size by Country (2021–2026)
9.4 Latin America Emphysema Treatment Medication Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Emphysema Treatment Medication Market Size (2021–2032)
10.2 Middle East & Africa Emphysema Treatment Medication Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Emphysema Treatment Medication Market Size by Country (2021–2026)
10.4 Middle East & Africa Emphysema Treatment Medication Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Emphasys Medical
11.1.1 Emphasys Medical Company Details
11.1.2 Emphasys Medical Business Overview
11.1.3 Emphasys Medical Emphysema Treatment Medication Introduction
11.1.4 Emphasys Medical Revenue in Emphysema Treatment Medication Business (2021–2026)
11.1.5 Emphasys Medical Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Emphysema Treatment Medication Introduction
11.2.4 Pfizer Revenue in Emphysema Treatment Medication Business (2021–2026)
11.2.5 Pfizer Recent Development
11.3 Uptake Medical
11.3.1 Uptake Medical Company Details
11.3.2 Uptake Medical Business Overview
11.3.3 Uptake Medical Emphysema Treatment Medication Introduction
11.3.4 Uptake Medical Revenue in Emphysema Treatment Medication Business (2021–2026)
11.3.5 Uptake Medical Recent Development
11.4 Inogen, Inc
11.4.1 Inogen, Inc Company Details
11.4.2 Inogen, Inc Business Overview
11.4.3 Inogen, Inc Emphysema Treatment Medication Introduction
11.4.4 Inogen, Inc Revenue in Emphysema Treatment Medication Business (2021–2026)
11.4.5 Inogen, Inc Recent Development
11.5 Viatris Inc
11.5.1 Viatris Inc Company Details
11.5.2 Viatris Inc Business Overview
11.5.3 Viatris Inc Emphysema Treatment Medication Introduction
11.5.4 Viatris Inc Revenue in Emphysema Treatment Medication Business (2021–2026)
11.5.5 Viatris Inc Recent Development
11.6 Boehringer Ingelheim International GmbH
11.6.1 Boehringer Ingelheim International GmbH Company Details
11.6.2 Boehringer Ingelheim International GmbH Business Overview
11.6.3 Boehringer Ingelheim International GmbH Emphysema Treatment Medication Introduction
11.6.4 Boehringer Ingelheim International GmbH Revenue in Emphysema Treatment Medication Business (2021–2026)
11.6.5 Boehringer Ingelheim International GmbH Recent Development
11.7 Novartis AG
11.7.1 Novartis AG Company Details
11.7.2 Novartis AG Business Overview
11.7.3 Novartis AG Emphysema Treatment Medication Introduction
11.7.4 Novartis AG Revenue in Emphysema Treatment Medication Business (2021–2026)
11.7.5 Novartis AG Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Emphysema Treatment Medication Introduction
11.8.4 AstraZeneca Revenue in Emphysema Treatment Medication Business (2021–2026)
11.8.5 AstraZeneca Recent Development
11.9 Orion Corporation
11.9.1 Orion Corporation Company Details
11.9.2 Orion Corporation Business Overview
11.9.3 Orion Corporation Emphysema Treatment Medication Introduction
11.9.4 Orion Corporation Revenue in Emphysema Treatment Medication Business (2021–2026)
11.9.5 Orion Corporation Recent Development
11.10 Teva Pharmaceutical Industries Ltd
11.10.1 Teva Pharmaceutical Industries Ltd Company Details
11.10.2 Teva Pharmaceutical Industries Ltd Business Overview
11.10.3 Teva Pharmaceutical Industries Ltd Emphysema Treatment Medication Introduction
11.10.4 Teva Pharmaceutical Industries Ltd Revenue in Emphysema Treatment Medication Business (2021–2026)
11.10.5 Teva Pharmaceutical Industries Ltd Recent Development
11.11 Verona Pharma Plc
11.11.1 Verona Pharma Plc Company Details
11.11.2 Verona Pharma Plc Business Overview
11.11.3 Verona Pharma Plc Emphysema Treatment Medication Introduction
11.11.4 Verona Pharma Plc Revenue in Emphysema Treatment Medication Business (2021–2026)
11.11.5 Verona Pharma Plc Recent Development
11.12 GlaxoSmithKline Plc
11.12.1 GlaxoSmithKline Plc Company Details
11.12.2 GlaxoSmithKline Plc Business Overview
11.12.3 GlaxoSmithKline Plc Emphysema Treatment Medication Introduction
11.12.4 GlaxoSmithKline Plc Revenue in Emphysema Treatment Medication Business (2021–2026)
11.12.5 GlaxoSmithKline Plc Recent Development
11.13 Pulmonx
11.13.1 Pulmonx Company Details
11.13.2 Pulmonx Business Overview
11.13.3 Pulmonx Emphysema Treatment Medication Introduction
11.13.4 Pulmonx Revenue in Emphysema Treatment Medication Business (2021–2026)
11.13.5 Pulmonx Recent Development
11.14 Bioxyne
11.14.1 Bioxyne Company Details
11.14.2 Bioxyne Business Overview
11.14.3 Bioxyne Emphysema Treatment Medication Introduction
11.14.4 Bioxyne Revenue in Emphysema Treatment Medication Business (2021–2026)
11.14.5 Bioxyne Recent Development
11.15 Intrexon
11.15.1 Intrexon Company Details
11.15.2 Intrexon Business Overview
11.15.3 Intrexon Emphysema Treatment Medication Introduction
11.15.4 Intrexon Revenue in Emphysema Treatment Medication Business (2021–2026)
11.15.5 Intrexon Recent Development
11.16 Icure Pharmaceuticals
11.16.1 Icure Pharmaceuticals Company Details
11.16.2 Icure Pharmaceuticals Business Overview
11.16.3 Icure Pharmaceuticals Emphysema Treatment Medication Introduction
11.16.4 Icure Pharmaceuticals Revenue in Emphysema Treatment Medication Business (2021–2026)
11.16.5 Icure Pharmaceuticals Recent Development
11.17 Kamada
11.17.1 Kamada Company Details
11.17.2 Kamada Business Overview
11.17.3 Kamada Emphysema Treatment Medication Introduction
11.17.4 Kamada Revenue in Emphysema Treatment Medication Business (2021–2026)
11.17.5 Kamada Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Emphysema Treatment Medication Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Bronchodilators
Table 3. Key Players of Steroids
Table 4. Key Players of Others
Table 5. Global Emphysema Treatment Medication Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Emphysema Treatment Medication Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Emphysema Treatment Medication Market Size by Region (US$ Million), 2021–2026
Table 8. Global Emphysema Treatment Medication Market Share by Region (2021–2026)
Table 9. Global Emphysema Treatment Medication Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Emphysema Treatment Medication Market Share by Region (2027–2032)
Table 11. Emphysema Treatment Medication Market Trends
Table 12. Emphysema Treatment Medication Market Drivers
Table 13. Emphysema Treatment Medication Market Challenges
Table 14. Emphysema Treatment Medication Market Restraints
Table 15. Global Emphysema Treatment Medication Revenue by Players (US$ Million), 2021–2026
Table 16. Global Emphysema Treatment Medication Market Share by Players (2021–2026)
Table 17. Global Top Emphysema Treatment Medication Players by Tier (Tier 1, Tier 2, and Tier 3), based on Emphysema Treatment Medication Revenue, 2025
Table 18. Ranking of Global Top Emphysema Treatment Medication Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Emphysema Treatment Medication Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Emphysema Treatment Medication, Headquarters and Area Served
Table 21. Global Key Players of Emphysema Treatment Medication, Products and Applications
Table 22. Global Key Players of Emphysema Treatment Medication, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Emphysema Treatment Medication Market Size by Type (US$ Million), 2021–2026
Table 25. Global Emphysema Treatment Medication Revenue Market Share by Type (2021–2026)
Table 26. Global Emphysema Treatment Medication Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Emphysema Treatment Medication Revenue Market Share by Type (2027–2032)
Table 28. Global Emphysema Treatment Medication Market Size by Application (US$ Million), 2021–2026
Table 29. Global Emphysema Treatment Medication Revenue Market Share by Application (2021–2026)
Table 30. Global Emphysema Treatment Medication Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Emphysema Treatment Medication Revenue Market Share by Application (2027–2032)
Table 32. North America Emphysema Treatment Medication Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Emphysema Treatment Medication Market Size by Country (US$ Million), 2021–2026
Table 34. North America Emphysema Treatment Medication Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Emphysema Treatment Medication Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Emphysema Treatment Medication Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Emphysema Treatment Medication Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Emphysema Treatment Medication Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Emphysema Treatment Medication Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Emphysema Treatment Medication Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Emphysema Treatment Medication Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Emphysema Treatment Medication Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Emphysema Treatment Medication Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Emphysema Treatment Medication Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Emphysema Treatment Medication Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Emphysema Treatment Medication Market Size by Country (US$ Million), 2027–2032
Table 47. Emphasys Medical Company Details
Table 48. Emphasys Medical Business Overview
Table 49. Emphasys Medical Emphysema Treatment Medication Product
Table 50. Emphasys Medical Revenue in Emphysema Treatment Medication Business (US$ Million), 2021–2026
Table 51. Emphasys Medical Recent Development
Table 52. Pfizer Company Details
Table 53. Pfizer Business Overview
Table 54. Pfizer Emphysema Treatment Medication Product
Table 55. Pfizer Revenue in Emphysema Treatment Medication Business (US$ Million), 2021–2026
Table 56. Pfizer Recent Development
Table 57. Uptake Medical Company Details
Table 58. Uptake Medical Business Overview
Table 59. Uptake Medical Emphysema Treatment Medication Product
Table 60. Uptake Medical Revenue in Emphysema Treatment Medication Business (US$ Million), 2021–2026
Table 61. Uptake Medical Recent Development
Table 62. Inogen, Inc Company Details
Table 63. Inogen, Inc Business Overview
Table 64. Inogen, Inc Emphysema Treatment Medication Product
Table 65. Inogen, Inc Revenue in Emphysema Treatment Medication Business (US$ Million), 2021–2026
Table 66. Inogen, Inc Recent Development
Table 67. Viatris Inc Company Details
Table 68. Viatris Inc Business Overview
Table 69. Viatris Inc Emphysema Treatment Medication Product
Table 70. Viatris Inc Revenue in Emphysema Treatment Medication Business (US$ Million), 2021–2026
Table 71. Viatris Inc Recent Development
Table 72. Boehringer Ingelheim International GmbH Company Details
Table 73. Boehringer Ingelheim International GmbH Business Overview
Table 74. Boehringer Ingelheim International GmbH Emphysema Treatment Medication Product
Table 75. Boehringer Ingelheim International GmbH Revenue in Emphysema Treatment Medication Business (US$ Million), 2021–2026
Table 76. Boehringer Ingelheim International GmbH Recent Development
Table 77. Novartis AG Company Details
Table 78. Novartis AG Business Overview
Table 79. Novartis AG Emphysema Treatment Medication Product
Table 80. Novartis AG Revenue in Emphysema Treatment Medication Business (US$ Million), 2021–2026
Table 81. Novartis AG Recent Development
Table 82. AstraZeneca Company Details
Table 83. AstraZeneca Business Overview
Table 84. AstraZeneca Emphysema Treatment Medication Product
Table 85. AstraZeneca Revenue in Emphysema Treatment Medication Business (US$ Million), 2021–2026
Table 86. AstraZeneca Recent Development
Table 87. Orion Corporation Company Details
Table 88. Orion Corporation Business Overview
Table 89. Orion Corporation Emphysema Treatment Medication Product
Table 90. Orion Corporation Revenue in Emphysema Treatment Medication Business (US$ Million), 2021–2026
Table 91. Orion Corporation Recent Development
Table 92. Teva Pharmaceutical Industries Ltd Company Details
Table 93. Teva Pharmaceutical Industries Ltd Business Overview
Table 94. Teva Pharmaceutical Industries Ltd Emphysema Treatment Medication Product
Table 95. Teva Pharmaceutical Industries Ltd Revenue in Emphysema Treatment Medication Business (US$ Million), 2021–2026
Table 96. Teva Pharmaceutical Industries Ltd Recent Development
Table 97. Verona Pharma Plc Company Details
Table 98. Verona Pharma Plc Business Overview
Table 99. Verona Pharma Plc Emphysema Treatment Medication Product
Table 100. Verona Pharma Plc Revenue in Emphysema Treatment Medication Business (US$ Million), 2021–2026
Table 101. Verona Pharma Plc Recent Development
Table 102. GlaxoSmithKline Plc Company Details
Table 103. GlaxoSmithKline Plc Business Overview
Table 104. GlaxoSmithKline Plc Emphysema Treatment Medication Product
Table 105. GlaxoSmithKline Plc Revenue in Emphysema Treatment Medication Business (US$ Million), 2021–2026
Table 106. GlaxoSmithKline Plc Recent Development
Table 107. Pulmonx Company Details
Table 108. Pulmonx Business Overview
Table 109. Pulmonx Emphysema Treatment Medication Product
Table 110. Pulmonx Revenue in Emphysema Treatment Medication Business (US$ Million), 2021–2026
Table 111. Pulmonx Recent Development
Table 112. Bioxyne Company Details
Table 113. Bioxyne Business Overview
Table 114. Bioxyne Emphysema Treatment Medication Product
Table 115. Bioxyne Revenue in Emphysema Treatment Medication Business (US$ Million), 2021–2026
Table 116. Bioxyne Recent Development
Table 117. Intrexon Company Details
Table 118. Intrexon Business Overview
Table 119. Intrexon Emphysema Treatment Medication Product
Table 120. Intrexon Revenue in Emphysema Treatment Medication Business (US$ Million), 2021–2026
Table 121. Intrexon Recent Development
Table 122. Icure Pharmaceuticals Company Details
Table 123. Icure Pharmaceuticals Business Overview
Table 124. Icure Pharmaceuticals Emphysema Treatment Medication Product
Table 125. Icure Pharmaceuticals Revenue in Emphysema Treatment Medication Business (US$ Million), 2021–2026
Table 126. Icure Pharmaceuticals Recent Development
Table 127. Kamada Company Details
Table 128. Kamada Business Overview
Table 129. Kamada Emphysema Treatment Medication Product
Table 130. Kamada Revenue in Emphysema Treatment Medication Business (US$ Million), 2021–2026
Table 131. Kamada Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
Table 135. Authors List of This Report
List of Figures
Figure 1. Emphysema Treatment Medication Picture
Figure 2. Global Emphysema Treatment Medication Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Emphysema Treatment Medication Market Share by Type: 2025 vs 2032
Figure 4. Bronchodilators Features
Figure 5. Steroids Features
Figure 6. Others Features
Figure 7. Global Emphysema Treatment Medication Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Emphysema Treatment Medication Market Share by Application: 2025 vs 2032
Figure 9. Hospitals Case Studies
Figure 10. Homecare Case Studies
Figure 11. Others Case Studies
Figure 12. Emphysema Treatment Medication Report Years Considered
Figure 13. Global Emphysema Treatment Medication Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Emphysema Treatment Medication Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Emphysema Treatment Medication Market Share by Region: 2025 vs 2032
Figure 16. Global Emphysema Treatment Medication Market Share by Players in 2025
Figure 17. Global Emphysema Treatment Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Emphysema Treatment Medication Revenue in 2025
Figure 19. North America Emphysema Treatment Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Emphysema Treatment Medication Market Share by Country (2021–2032)
Figure 21. United States Emphysema Treatment Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Emphysema Treatment Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Emphysema Treatment Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Emphysema Treatment Medication Market Share by Country (2021–2032)
Figure 25. Germany Emphysema Treatment Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Emphysema Treatment Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Emphysema Treatment Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Emphysema Treatment Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Emphysema Treatment Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Emphysema Treatment Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Emphysema Treatment Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Emphysema Treatment Medication Market Share by Region (2021–2032)
Figure 33. China Emphysema Treatment Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Emphysema Treatment Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Emphysema Treatment Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Emphysema Treatment Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Emphysema Treatment Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Emphysema Treatment Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Emphysema Treatment Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Emphysema Treatment Medication Market Share by Country (2021–2032)
Figure 41. Mexico Emphysema Treatment Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Emphysema Treatment Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Emphysema Treatment Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Emphysema Treatment Medication Market Share by Country (2021–2032)
Figure 45. Israel Emphysema Treatment Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Emphysema Treatment Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Emphysema Treatment Medication Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Emphasys Medical Revenue Growth Rate in Emphysema Treatment Medication Business (2021–2026)
Figure 49. Pfizer Revenue Growth Rate in Emphysema Treatment Medication Business (2021–2026)
Figure 50. Uptake Medical Revenue Growth Rate in Emphysema Treatment Medication Business (2021–2026)
Figure 51. Inogen, Inc Revenue Growth Rate in Emphysema Treatment Medication Business (2021–2026)
Figure 52. Viatris Inc Revenue Growth Rate in Emphysema Treatment Medication Business (2021–2026)
Figure 53. Boehringer Ingelheim International GmbH Revenue Growth Rate in Emphysema Treatment Medication Business (2021–2026)
Figure 54. Novartis AG Revenue Growth Rate in Emphysema Treatment Medication Business (2021–2026)
Figure 55. AstraZeneca Revenue Growth Rate in Emphysema Treatment Medication Business (2021–2026)
Figure 56. Orion Corporation Revenue Growth Rate in Emphysema Treatment Medication Business (2021–2026)
Figure 57. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Emphysema Treatment Medication Business (2021–2026)
Figure 58. Verona Pharma Plc Revenue Growth Rate in Emphysema Treatment Medication Business (2021–2026)
Figure 59. GlaxoSmithKline Plc Revenue Growth Rate in Emphysema Treatment Medication Business (2021–2026)
Figure 60. Pulmonx Revenue Growth Rate in Emphysema Treatment Medication Business (2021–2026)
Figure 61. Bioxyne Revenue Growth Rate in Emphysema Treatment Medication Business (2021–2026)
Figure 62. Intrexon Revenue Growth Rate in Emphysema Treatment Medication Business (2021–2026)
Figure 63. Icure Pharmaceuticals Revenue Growth Rate in Emphysema Treatment Medication Business (2021–2026)
Figure 64. Kamada Revenue Growth Rate in Emphysema Treatment Medication Business (2021–2026)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
